Life Sciences Drug DevelopmentFramingham, MA
Synspira Therapeutics is a clinical-stage biopharmaceutical company dedicated to significantly improving the lives of people with cystic fibrosis and other rare diseases where there is a high unmet treatment need. Synspira is a privately held company headquartered in Framingham, MA. Our lead product, SNSP-113, is a first-of-its-kind product with a broad spectrum mechanism of action designed to target the underlying cascade of events that lead to progressive pulmonary disease or other life-threatening pulmonary conditions. At Synspira we are inspired by the patients we serve and are driven to make a difference.